Note: Subscribers to Avisol Capital Partners Total Pharma Tracker got an early look at this publication.
Welcome to another edition of "3 Things In Biotech" a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotechnology research.
Shire enters the home stretch with its newer formulation of asparaginase
Company: Shire Group (SHPG)
Therapy: Calaspargase pegol
Disease: Acute lymphoblastic leukemia
News: SHPG announced that the FDA has accepted the application for approval for its newer formulation of asparaginase called calaspargase pegol. Currently, this agent is approved in Europe,